SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cowen & Co. Upgrades Hologic to Outperform, Announces $64 Price Target

Cowen & Co. analyst Doug Schenkel upgrades Hologic (NASDAQ:HOLX) from Market Perform to Outperform and announces $64 price target.

Benzinga · -
Cowen & Co. analyst Doug Schenkel upgrades Hologic (NASDAQ: HOLX) from Market Perform to Outperform and announces $64 price target.